Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism PAR-2 antagonists(Protease-activated receptor-2 antagonists), VAP-1 inhibitors(Amine oxidase, copper containing inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Preclinical | United Kingdom | - | |
Dermatitis, Atopic | Preclinical | United Kingdom | - | |
Inflammatory pain | Preclinical | United Kingdom | - | |
Irritable Bowel Syndrome | Preclinical | United Kingdom | - | |
Neoplasms | Preclinical | United Kingdom | - |